Case-Based Roundtable Meetings Spotlight
Case-Based Roundtable Meeting Spotlight October 2 2021
Case-Based Roundtable Meeting Spotlight September 2021:Hematologic Malignancies
Case-Based Roundtable Meeting Spotlight September 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight August 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight August 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight July 1 2021
Case-Based Roundtable Meetings Spotlight July 2 2021
Case-Based Roundtable Meetings Spotlight June 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight June 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight May 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight May 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight April 2, 2021
Case-Based Roundtable Meetings Spotlight April 1, 2021
Case-Based Roundtable Meetings Spotlight March 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight March 2021: Hematologic Malignancies
Case-Based Roundtable Meeting Spotlight February 2 2021
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
2
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC
5